SenzaGen
  • Home
  • Services
    • GARD: Sensitization Testing
    • Regulatory Toxicity Testing
    • Medical Device Services
    • Toxicology Advisory
    • Difficult-to-test
    • Who we work with
  • Science
    • GARD Technology
    • Science Behind
    • Scientific Publications
    • Posters
    • Webinars
  • Company
    • About Us
    • Sustainability
    • Career
    • Partners
  • Investors
    • SenzaGen at a Glance
    • Financial Reports
    • Press Releases
    • The Share
    • Analyst Coverage
    • Presentations
    • Corporate Governance
      • Management
      • Board of Directors
      • Auditor
      • Nomination Committee
      • Annual General Meeting
    • Calendar
    • Prospekt / Emission
  • News and Events
    • Press Releases
    • News Posts
    • Event Calendar
  • Contact
  • Get a quote
  • Search
  • Menu Menu

Vatorpodden – intervju med VD och styrelseordförande

1 September, 2017

Share this entry
  • Share on Facebook
  • Share on X
  • Share on WhatsApp
  • Share on LinkedIn
  • Share on Vk
  • Share on Reddit
  • Share by Mail
https://senzagen.extendio.se/wp-content/uploads/2017/07/e9262d9e897187a751b838082c4fe811.jpeg 400 266 Malin Bergholm https://senzagen.extendio.se/wp-content/uploads/2017/01/LoggaSquare_RGB_liten_HF.png Malin Bergholm2017-09-01 12:16:272018-08-23 15:41:00Vatorpodden – intervju med VD och styrelseordförande

Quick Links

Contact
Privacy Policy (En)
Privacy Policy (Sv)
General Terms and Conditions

Pages

  • Home
  • Services
  • Investors
  • Contact
  • News and Events

Follow Us

SUBSCRIBE TO PRESS RELEASES

Driving innovation and serving industry end-to-end

From innovative sensitization testing with GARD® to biological evaluation of Medical Devices, we offer both standard regulatory toxicity assessments and customized studies.

SenzaGen’s chairman Carl Borrebaeck has received the Biotech Builders...SenzaGen offentliggör prospekt inför listning på Nasdaq First North
Scroll to top

Subscribe


Prenumerera